Nu-Med

Elblag, Poland Founded: 2017 • Age: 9 yrs Acquired By Affidea
Standalone general clinic
Annual revenue - Latest available
Total funding - 1 rounds
Employees - Tracked headcount
Investors 2 Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Nu-Med

Nu-Med is a company based in Elblag (Poland) founded in 2017 was acquired by Affidea in August 2024. Nu-Med offers products and services including Radiotherapy and Diagnostic Imaging.

  • Headquarter Elblag, Poland
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Nu-Med Grupa S.A.
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $45.95 M (USD), Debt – Conventional

    Oct 31, 2023

  • Investors
    mBank

    & 1 more

  • Employee Count
    Employee Count
  • Acquired by
    Affidea

    (Aug 27, 2024)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Nu-Med

Nu-Med offers a comprehensive portfolio of products and services, including Radiotherapy and Diagnostic Imaging.

Primary

Radiotherapy is employed as a method for treating malignant tumors and certain non-oncological conditions.

Diagnostic imaging is utilized to perform scans like CT and MRI for the detection and monitoring of diseases.

Funding Insights of Nu-Med

  • Total Funding
  • Total Rounds 1
  • Last Round Debt – Conventional — $46.0M
  • First Round

    (31 Oct 2023)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Oct, 2023 Amount Debt – Conventional - Nu-Med Valuation

investors

Investors in Nu-Med

Nu-Med has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include mBank and Affidea.

All
Institutional
Investor Description Founded Year Domain Location
Commercial banking services are provided in Poland.
Founded Year Domain Location
Diagnostic imaging and cancer treatment services are delivered pan-European.
Founded Year Domain Location

Investments & Acquisitions by Nu-Med

Investments

Financial Statements - Nu-Med

Nu-Med Comparisons

+
Add Comparison
Available on Premium

Competitors of Nu-Med

Latest news on Nu-Med

Frequently Asked Questions about Nu-Med

Nu-Med was founded in 2017 and raised its 1st funding round 6 years after it was founded.

Nu-Med is headquartered in Elblag, Poland. It is registered at Elblag, Warmian-masurian Voivodeship, Poland.

Nu-Med was established in 2017 as a standalone general clinic based in Elblag, Poland. Primary healthcare services, including consultations and treatments, are offered to local patients. Operations are conducted independently, without integration into larger medical networks. The clinic focuses on routine medical care within the healthcare sector, serving the regional community through its domain nu-med.pl. Standard diagnostic and therapeutic procedures are handled on-site.

Nu-Med offers Radiotherapy and Diagnostic Imaging.

Nu-Med has 2 investors. Key investors include mBank, and Affidea.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available